- Home
- ALZN vs MEGL Comparison
ALZN vs MEGL Comparison
Compare ALZN & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- MEGL
- Stock Information
- Founded
- ALZN 2016
- MEGL 2016
- Country
- ALZN United States
- MEGL Hong Kong
- Employees
- ALZN N/A
- MEGL N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- MEGL Finance: Consumer Services
- Sector
- ALZN Health Care
- MEGL Finance
- Exchange
- ALZN Nasdaq
- MEGL Nasdaq
- Market Cap
- ALZN 8.2M
- MEGL 6.8M
- IPO Year
- ALZN 2021
- MEGL 2022
- Fundamental
- Price
- ALZN $2.53
- MEGL N/A
- Analyst Decision
- ALZN Strong Buy
- MEGL
- Analyst Count
- ALZN 1
- MEGL 0
- Target Price
- ALZN $42.00
- MEGL N/A
- AVG Volume (30 Days)
- ALZN 170.2K
- MEGL 49.5K
- Earning Date
- ALZN 09-10-2025
- MEGL 10-29-2025
- Dividend Yield
- ALZN N/A
- MEGL N/A
- EPS Growth
- ALZN N/A
- MEGL N/A
- EPS
- ALZN N/A
- MEGL N/A
- Revenue
- ALZN N/A
- MEGL $1,645,862.00
- Revenue This Year
- ALZN N/A
- MEGL N/A
- Revenue Next Year
- ALZN N/A
- MEGL N/A
- P/E Ratio
- ALZN N/A
- MEGL N/A
- Revenue Growth
- ALZN N/A
- MEGL N/A
- 52 Week Low
- ALZN $2.06
- MEGL $1.02
- 52 Week High
- ALZN $17.10
- MEGL $5.52
- Technical
- Relative Strength Index (RSI)
- ALZN 52.36
- MEGL 66.35
- Support Level
- ALZN $2.33
- MEGL $1.53
- Resistance Level
- ALZN $2.55
- MEGL $1.90
- Average True Range (ATR)
- ALZN 0.10
- MEGL 0.09
- MACD
- ALZN 0.02
- MEGL 0.02
- Stochastic Oscillator
- ALZN 66.07
- MEGL 71.84
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.